Delivery Order SPE2DB20D3103-SPE2DB24FN2B0
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $1,216.11 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of Envarsus XR 1 mg tablets. This order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under this IDC, AmerisourceBergen provides a wide range of pharmaceutical products and medical supplies to support the...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, a firm fixed price delivery order contract worth $1,216.11 for the supply of Envarsus XR 1 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical...
- The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, has awarded a delivery order contract to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,621.48 firm fixed price contract is for the delivery of Envarsus XR 1 mg tablets to support military treatment programs and facilities. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, valued at $1,465.68, for the supply of the pharmaceutical product ENVARSUS XR 1 MG TABLET 30S. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution company. The $1,621.48 order is for the supply of the pharmaceutical product Envarsus XR 1 mg Tablet 100s. The order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceuticals...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,711.95 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of ENVARSUS XR 4 MG TABLET 100S. The contract has a completion date of July 1, 2025 and is not a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00,...
- This federal contract award, valued at $5,135.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Envarsus XR 4 mg tablets, a pharmaceutical product, with a performance period through May 27, 2025. This contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,099.26, is for the delivery of Envarsus XR 1 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the DLA to...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract, valued at $8,076.65, is for the delivery of Envarsus XR 4 mg tablets over a period ending on July 30, 2024. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,007.34, is for the delivery of Envarsus XR 1 mg tablets in quantities of 100. The contract is a firm fixed-price delivery order and is not set aside for any particular business type. Amerisourcebergen Drug Corp is the prime contractor, and the contract will be performed in Conshohocken,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN2B0Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,198.52 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product Envarsus XR 1 mg tablet. This delivery order was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This contract does not have a set-aside designation. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 3/27/24 |